Rockwell Medical Reports Q3 2026 Results and Announces Vantive Limited Acquisition
Rockwell Medical (RMTI) reported third-quarter revenue of $19.1 million, a 20% year-over-year increase driven by higher purchasing volumes from major U.S. dialysis providers and expansion in the Western U.S. While gross profit rose 37% to $3.1 million with expanding margins, the company reported a net loss of $2.3 million, largely due to transaction costs related to its upcoming acquisition of Vantive Limited's global hemodialysis business. The pending acquisition is expected to close in mid-2027 and will significantly scale the company's footprint, adding machines, water treatment systems, and a manufacturing campus in Italy. Management projects that the combined entity will generate between $400 million and $450 million in annual revenue, with approximately 90% of that revenue expected to be recurring.